郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.

期刊:Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology发表年份:2015作者:Bogna M Ignatowska-Jankowska; Gemma L Baillie; Steven Kinsey; Molly Crowe; Sudeshna Ghosh; Robert A Owens; Imad M Damaj; Justin Poklis; Jenny L Wiley; Matteo Zanda; Chiara Zanato; Iain R Greig; Aron H Lichtman; Ruth A Ross

药效评价Real-time product attribute control to manufacture antibodies with defined N-linked glycan levels.

期刊:Biotechnology progress发表年份:2015作者:Craig Zupke; Lowell J Brady; Peter G Slade; Philip Clark; R Guy Caspary; Brittney Livingston; Lisa Taylor; Kyle Bigham; Arvia E Morris; Robert W Bailey

药效评价Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation.

期刊:British journal of pharmacology发表年份:2015作者:Lingxin Wang; Shannon G Zellmer; David M Printzenhoff; Neil A Castle

药效评价Anxiogenic and Stressor Effects of the Hypothalamic Neuropeptide RFRP-3 Are Overcome by the NPFFR Antagonist GJ14.

期刊:Endocrinology发表年份:2015作者:Joon S Kim; Phil W Brownjohn; Blake S Dyer; Massimiliano Beltramo; Christopher S Walker; Debbie L Hay; Gavin F Painter; Joel D A Tyndall; Greg M Anderson